XML 46 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Warrants
 12 Months Ended
Dec. 31, 2020
Warrant Disclosure [Abstract]  
Warrants

(13) Warrants


Pursuant to the 2020 Purchase Agreement, the Company agreed to sell to such investors an aggregate of 4,400,000 shares of common stock and warrants to purchase up to 4,400,000 shares of the Common Stock in a concurrent private placement. The exercise price of the warrant is $0.7425 per share. These warrants are exercisable on November 4, 2020 and have a term of exercise equal to five years and six months from the date of issuance till November 4, 2025. The Company classified warrant as liabilities and accounted for the issuance of the Warrants as a derivative.


A summary of stock warrant activities is as below:


   Year Ended 
   December 31,
2020		 
       Weight 
       average 
       exercise 
   Number   price 
Outstanding and exercisable at beginning of the period        
Issued during the period   4,400,000   $0.7425 
Exercised during the period   -    - 
Cancelled or expired during the period   -    - 
Outstanding and exercisable at end of the period   4,400,000   $0.7425 

The following table summarizes information relating to outstanding and exercisable warrants as of December 31, 2020.


Warrants Outstanding   Warrants Exercisable 
    Weighted             
    Average   Weighted       Weighted  
   Remaining   Average      Average 
Number of   Contractual life   Exercise   Number of   Exercise 
Shares   (in years)   Price   Shares   Price 
 4,400,000    4.84   $0.7425    4,400,000   $0.7425 

Aggregate intrinsic value is the sum of the amounts by which the quoted market price of the Company’s stock exceeded the exercise price of the warrants at December 31, 2020 for those warrants for which the quoted market price was in excess of the exercise price (“in-the-money” warrants). There is no intrinsic value of the warrants as of December 31, 2020.